Real-time enrollment status for this acute lymphoblastic leukemia, in relapse clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 4:01 AM UTC
| NCT Number | NCT04881240 |
| Recruiting Status | Recruiting |
| Condition | Acute Lymphoblastic Leukemia, in Relapse |
| Phase | PHASE1 |
| Target Enrollment | 60 participants |
| Active Locations | 1 sites in the US |
| Sponsor | St. Jude Children's Research Hospital |
| Last Updated on CT.gov | May 26, 2026 (May 26, 2026) |
As of July 18, 2026: Clinical trial NCT04881240 is currently recruiting participants. This phase1 study for acute lymphoblastic leukemia, in relapse is actively seeking new participants at 1 location across the United States. The study is sponsored by St. Jude Children's Research Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04881240 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04881240 was last updated May 26, 2026 (May 26, 2026). HelloStudys verifies this status automatically.